FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis – The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS).
Gene variation associated with lower risk of dementia, Alzheimer disease – Preliminary research suggests that variation of a gene for a plasma protein is associated with slower age-related memory decline and a lower risk of dementia and Alzheimer disease (AD).
Study reveals how one form of natural vitamin E protects brain after stroke – Blocking the function of an enzyme in the brain with a specific kind of vitamin E can prevent nerve cells from dying after a stroke, new research suggests.
Aerobic exercise has a better effect on cognition and other biomarkers associated with Alzheimer disease pathology for older adults with mild cognitive impairment. – Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition.
University Hospitals Case Medical Center testing gene therapy for Alzheimer’s disease — Phase 2 study will examine effectiveness, safety of nerve growth factor in slowing AD – University Hospitals Case Medical Center is one of 12 sites conducting the first Phase 2 clinical trial of a gene therapy for Alzheimer’s disease (AD). The study uses a viral-based gene transfer system called CERE-110, which is designed to deliver nerve growth factor (NGF) into the brain.
Cell phone exposure may protect against and reverse Alzheimer’s disease — Florida Alzheimer’s Disease Research Center study in mice indicates long-term exposure to cell phone signals may even boost normal memory. – The millions of people who spend hours every day on a cell phone may have a new excuse for yakking. A surprising new study in mice provides the first evidence that long-term exposure to electromagnetic waves associated with cell phone use may actually protect against, and even reverse, Alzheimer’s disease.
Compared with placebo, the use of G biloba, 120 mg twice daily, did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment. – Older adults who used the herbal supplement Ginkgo biloba for several years did not have a slower rate of cognitive decline compared to adults who received placebo.
Researchers find high leptin levels may protect against Alzheimer’s disease and dementia – Researchers from Boston University School of Medicine (BUSM) have found that higher leptin (a protein that controls weight and appetite) levels were associated with a lower incidence of Alzheimer’s Disease (AD) and dementia.
Green tea chemical combined with another may hold promise for treatment of brain disorders – Researchers have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer’s, Huntington’s, and Parkinson’s diseases.
New study finds men and women may respond differently to danger – Men and women respond differently to positive and negative stimuli, revealed by researchers in a study presented at the annual meeting of the Radiological Society of North America (RSNA).
Hormone ghrelin can boost resistance to Parkinson’s disease – Stomach hormone – Ghrelin – may be used to boost resistance to, or slow, the development of Parkinson’s disease, Yale School of Medicine researchers report in a study published in the Journal of Neuroscience.
New Down syndrome treatment suggested by Stanford/Packard study — Cognitive dysfunction reversed in mouse model of Down syndrome. – Findings from the Stanford University School of Medicine and Lucile Packard Children’s Hospital shed light on the neural basis of memory defects in Down syndrome and suggest a new strategy for treating the defects with medication.
